Clinical Trial Update: Possible Protective Effect of Celecoxib Against Capecitabine Induced Hand and Foot Syndrome in Patients With Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial investigating whether celecoxib can protect against capecitabine-induced hand and foot syndrome in colorectal cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Erythrodysesthesia Syndrome
• Hand and Foot Syndrome

Drugs mentioned

• Capecitabine (capecitabine)
• Celecoxib (Celecoxib)

Snippet

Sponsor: Tanta University | Conditions: Hand and Foot Syndrome, Erythrodysesthesia Syndrome | Phase 3 | Status: UNKNOWN